Oral Contraception and Some Debatable Side Effects

References

• Antoniades K., Brooks C. E., Jr. Hemoperitoneum from liver cell adenoma in a patient on oral contraceptives. Surgery 1975; 77: 137
   PubMed Web of Science ®Google Scholar
• Badaracco M. A., Vessey M. P. Recurrence of venous thromboembolic disease and use of oral contraceptives. Br Med J 1974; i: 215
   Google Scholar
• Bailar J. C. Thromboembolism and oestrogen therapy. Lancet 1967; ii: 560
   Google Scholar
• Bennion L. J., Ginsberg R. L., Garnick M. B., Bennett P. H. Effects of oral contraceptives on the gallbladder bile of normal women. N Engl J Med 1976; 294: 189
   PubMed Web of Science ®Google Scholar
• Beral D. V. Mortality among oral-contraceptive users. Lancet 1977; ii: 727
   Google Scholar
• Boyd W. N., Burden R. P., Aber G. M. Intrarenal vascular changes in patients receiving oestrogen-containing compounds. A clinical, histological, and angiographic study. J Med (New Series XLIV) 1975; 175: 415
   Google Scholar
• Briggs M. H. Thromboembolism and oral contraceptives. Br Med J 1974; ii: 503
   Google Scholar
• Briggs M. H., Briggs M. Effects of oral ethinylestradiol on serum proteins in normal women. Contraception 1971; 3: 381
   Web of Science ®Google Scholar
• Briggs M. H., Briggs M. Molecular biology and oral contraception. NZ Med J 1976; 83: 257
   Google Scholar
• Böttiger L. E., Boman G., Eklund G., Westerholm B. Oral contraceptives and thromboembolic disease: Effects of lowering oestrogen content. Lancet 1980; i: 1097
   Google Scholar
• Casagrande J. T., Pike M. C., Ross P. K., Louie E. W., Roy S., Henderson B. E. “Incessant ovulation” and ovarian cancer. Lancet 1979; ii: 170
   Google Scholar
• Daniel D. G., Campbell H., Turnbull A. C. Puerperal thromboembolism and suppression of lactation. Lancet 1967; ii: 287
   Google Scholar
• Doering G. K., Kauka E., Netzer A. Pregnancy and fetal outcome after cessation of oral contraceptives. Geburtsh Frauenheilkd 1976; 36: 57
   Google Scholar
• Dreyer N. A., Pizzo S. V. Blood coagulation and idiopathic thromboembolism among fertile women. Contraception 1980; 22: 123
   Google Scholar
• Drill V. A. Oral contraceptives and thromboembolic disease. I. Prospective and retrospective studies. JAMA 1972; 219: 583
   Google Scholar
• Drill V. A., Calhoun D. W. oral contraceptives and thromboembolic disease. JAMA 1968; 206: 77
   PubMed Web of Science ®Google Scholar
• Drill V. A., Calhoun D. W. Oral contraceptives and thromboembolic disease. II. Estrogen content of oral contraceptives. JAMA 1972; 219: 593
   Google Scholar
• Edmondson H. A., Henderson B., Benton B. Liver-cell adenomas associated with use of oral contraceptives. N Engl J Med 1976; 294: 470
   PubMed Web of Science ®Google Scholar
• Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thromb Haemostas 1965; 13: 516
   Google Scholar
• Fagerhol M. K., Abildgaard U., Bergsjö P., Jacobsen J. H. Oral contraceptives and low anti-thrombin-III concentration. Lancet 1970; i: 1175
   Google Scholar
• Fasal E., Paffenbarger R. S. Oral contraceptives as related to cancer and benign lesions of the breast. J Natl Cancer Inst 1975; 55: 767
   Google Scholar
• Fischer S. Fibrinolytic activity in human coronary arteries. Review and quantitative studies. Adv Cardiol 1970; 4: 187
   Google Scholar
• Frederick W. C., Howard R. G., Spatola S. Spontaneous rupture of the liver in patient using contraceptive pills. Arch Surg 1974; 108: 93
   Google Scholar
• Fuertes-de la Haba A., Curet J. O., Pelegrina I., Bandiwala I. Thrombophlebitis among oral and nonoral contraceptive users. Obstet Gynecol 1973; 38: 259
   Google Scholar
• Goldzieher W., Dozier T. S. Oral contraceptives and thromboembolism: a reassessment. Am J Obstet Gynecol 1975; 123: 878
   PubMed Web of Science ®Google Scholar
• Cow S., MacGillivray I. Metabolic, hormonal and vascular changes after synthetic oestrogen therapy in oophorectomized women. Br Med J 1971; ii: 73
   Google Scholar
• Grant E. C. G. Venous effects of oral contraceptives. Br Med J 1969; iv: 73
   Google Scholar
• Gustafsson J.-Å., Hagenfeldt K. P-piller och cancerrisk. Läkartidn 1979; 76: 1625
   Google Scholar
• Hedner U., Nilsson I. M. Antithrombin III in a clinical material. Thromb Res 1973; 3: 631
   Google Scholar
• Hermann R. E., David T. E. Spontaneous rupture of the liver caused by hepatomas. Surgery 1973; 74: 715
   Google Scholar
• Hougie C. Thromboembolism and oral contraceptives. Am Heart J 1973; 85: 538
   Google Scholar
• Howie P. W., Mallinson A. C., Prentice C. R. M., Horne C. H. W., McNicol G. P. Effect of combined oestrogen-progestogen oral contraceptives, oestrogen, and progestogen on antiplasmin and antithrombin activity. Lancet 1970; ii: 1329
   Google Scholar
• Inman W. H. W., Vessey M. P. Investigation of deaths from pulmonary, coronary and cerebral thrombosis and embolism in women of child-bearing age. Br Med J 1968; ii: 193
   Google Scholar
• Inman W. H. W., Vessey M. P., Westerholm B., Engelund A. Thromboembolic disease and the steroidal content of oral contraceptives. A report to the Committee on Safety of Drugs. Br Med J 1970; ii: 203
   Google Scholar
• Isacson S., Nilsson I. M. Defective fibrinolysis in blood and vein walls in recurrent “idiopathic” venous thrombosis. Acta Chir Scand 1972; 138: 313
   PubMedGoogle Scholar
• Jeffcoate T. N. A., Miller J., Roos R. F., Tindall V. R. Puerperal thromboembolism in relation to the inhibition of lactation by oestrogen therapy. Br Med J 1968; iv: 19
   Google Scholar
• Jeppsson S., Rannevik G. Effect of oral 17-beta-oestradiol on the liver in women with intrahepatic cholestasis (hepatosis) during previous pregnancies. Br J Obstet Gynaecol 1976; 83: 567
   Google Scholar
• Jardan W. M. Pulmonary embolism. Lancet 1961; ii: 1146
   Google Scholar
• Kaufman D. W., Shapiro S., Slone D., Rosenberg L., Miettinen O. S., Stolley P. D., Knapp R. C., Leavitt T., Jr., Watring W. G., Rosenshein N. B., Lewis J. L., Jr., Schottenfeld D., Engle R. L., Jr. Decreased risk of endometrial cancer among oral-contraceptive users. N Engl J Med 1980; 303: 1045
   PubMed Web of Science ®Google Scholar
• von Kaulla E., von Kaulla K. N. Antithrombin III and diseases. Am J Clin Pathol 1967; 48: 69
   PubMed Web of Science ®Google Scholar
• von Kaulla E., von Kaulla K. N. Oral contraceptives and low antithrombin-III activity. Lancet 1970; i: 36
   Google Scholar
• Kay C. R. Oral contraceptives and venous thrombosis. J R Coll Gen Pract 1975; 25: 904
   Google Scholar
• Kelley H. W., Miles P. A., Buster J. E., Scragg W. H. Adenocarcinoma of the endometrium in women taking sequential oral contraceptives. Obstet Gynecol 1976; 47: 200
   Google Scholar
• Kinch R., Lough J. Focal nodular hyperplasia of the liver and oral contraceptives. Am J Obstet Gynecol 1978; 132: 717
   Google Scholar
• Kindermann G. Begünstigt die “Pille” Krebs?. Geburtsh Frauenheilkd 1976; 36: 213
   Google Scholar
• Kubik M. M., Bhowmick B. K. Myocardial infarction and oral contraceptives. Br Heart J 1973; 35: 1271
   Google Scholar
• Lauritsen J. G. The significance of oral contraceptives in causing chromosome anomalies in spontaneous abortions. Acta Obstet Gynecol Scand 1975; 54: 261
   Google Scholar
• Low J., Oparil S. Oral contraceptive pill hypertension. J Reprod Med 1975; 15: 201
   PubMedGoogle Scholar
• Lund J. O., Jensen H. A. Orale contraceptiva og hypertension. Ugeskr Laeger 1975; 42: 2431
   Google Scholar
• Lundberg P.-O., Nilsson A.-C., Osterman P.-O. Cerebral tromboembolism hos unga kvinnor och män. Läkartidn 1975; 72: 1928
   Google Scholar
• Lyon F. A. Adenocarcinoma during long-term sequential oral contraception. Am J Obstet Gynecol 1975; 123: 299
   PubMed Web of Science ®Google Scholar
• Mann J. I., Inman W. H. W. Oral contraceptives and death from myocardial infarction. Br Med J 1975; ii: 245
   Google Scholar
• Mann J. I., Thorogood M., Waters W. E., Powell C. Oral contraceptives and myocardial infarction in young women. A further report. Br Med J 1975; iii: 631
   Google Scholar
• Mann J. I., Vessey M. P., Thorogood M., Doll R. Myocardial infarction in young women with special reference to oral contraceptive practice. Br Med J 1976; ii: 241
   Google Scholar
• McCarroll A. M., Montgomery D. A. D., Harley J. G. Endometrial carcinoma after cyclical oestrogen-progestogen therapy for Turner's syndrome. J Obstet Gynaecol Br Commonw 1975; 82: 421
   Google Scholar
• McQueen E. G. Oestrogen content of oral contraceptives and thrornboembolism. NZ Med J 1970; 71: 317
   Google Scholar
• Neuberger J., Nunnerley H. B., Davis M., Portmann B., Laws J. W., Williams R. Oral-contraceptive-associated liver tumours: Occurrence of malignancy and difficulties in diagnosis. Lancet 1980; i: 273
   Google Scholar
• Newhouse M. L., Pearson R. M., Fullerton J. M., Bocsen E. A. M., Shannon H. S. A case control study of carcinoma of the ovary. Br J Prev Soc Med 1977; 31: 148
   Google Scholar
• Nilsson I. M., Kullander S. Coagulation and fibrinolytic studies during use of gestagens. Acta Obstet Gynecol Scand 1967; 46: 286
   PubMed Web of Science ®Google Scholar
• Nilsson I. M., Kullander S., Åstedt B. Coagulation and fibrinolytic studies during continuous use of low dose gestagen. Acta Endocrinol (Kbh) 1970; 65: 111
   Google Scholar
• Nora J. J., Nora A. H., Perinshief A. G., Ingram J. W., Fountain A. G., Peterson M. J. Congenital abnormalities and first-trimester exposure to progestogen/oestrogen. Lancet 1976; i: 313
   Google Scholar
• Oliver M. F. Thrombosis and oestrogens. Lancet 1967; ii: 510
   Google Scholar
• Ory H., Cole P., MacMahon B., Hoover R. Oral contraceptives and reduced risk of benign breast diseases. N Engl J Med 1976; 294: 419
   PubMed Web of Science ®Google Scholar
• Pandolfi M., Robertson B., Isacson S., Nilsson I. M. Fibrinolytic activity of human veins in arms and legs. Thromb Haemostas 1968; 20: 247
   Google Scholar
• Radford D. J., Oliver M. F. Oral contraceptives and myocardial infarction. Br Med J 1973; iii: 428
   Google Scholar
• Rannevik G., Jeppsson S., Kullander S. Effect of oral contraceptives on the liver in women with recurrent cholestasis (hepatosis) during previous pregnancies. J Obstet Gynaecol Br Commonw 1972; 79: 1128
   PubMedGoogle Scholar
• Rothman K. J., Louik C. Oral contraceptives and birth defects. N Engl J Med 1978; 299: 322
   Google Scholar
• Sagar S., Thomas D. P., Stamatakis J. D., Kakkar V. V. Oral contraceptives, antithrombin-II activity, and postoperative deep-vein thrombosis. Lancet 1976; i: 509
   Google Scholar
• Sartwell P. E., Masi A. T., Arthes F. G., Greene G. R., Smith H. E. Thromboernbolism and oral contraceptives: an epidemiologic case-control study. Am J Epidemiol 1969; 90: 365
   PubMed Web of Science ®Google Scholar
• Shapiro S., Slone D., Rosenberg L., Kaufman D. W. Oral-contraceptive use in relation to myocardial infarction. Lancet 1979; i: 743
   Google Scholar
• Sherlock S. Progress report: hepatic adenomas and oral contraceptives. Gut 1975; 16: 753
   Google Scholar
• Silverberg S. G., Makowski E. L. Endometrial carcinoma in young women taking oral contraceptive agents. Obstet Gynecol 1975; 46: 503
   PubMed Web of Science ®Google Scholar
• Stevens R. G., Lee J. A. H., Moolgavkar S. H. No association between oral contraceptives and malignant melanomas. N Engl J Med 1980; 302: 966
   Google Scholar
• Stolley P. D., Tonascia J. A., Tockman M. S., Sartwell P. E., Rutledge A. H., Jacobs M. P. Thrombosis with low-estrogen oral contraceptives. Am J Epidemiol 1975; 102: 197
   PubMed Web of Science ®Google Scholar
• Vanderick G., Beernaert J., De Muylder E., Ferin J. Hormonal contraception. Sequential formulations and the endometrium. Contraception 1975; 12: 655
   Google Scholar
• Vessey M. P., Doll R. Investigation of relation between use of oral contraceptives and thromboembolic disease. Br Med J 1968; ii: 199
   Google Scholar
• Vessey M. P., Doll R. Investigation of relation between use of oral contraceptives and thromboembolic disease. Br Med J 1969; ii: 651
   Google Scholar
• Vessey M. P., Kay C. R., Baldwin J., Clarke J. A., Macleod I. Oral contraceptives and benign liver tumours. Br Med J 1977; ii: 1064
   Google Scholar
• Vessey M. P., McPherson K., Johnson B. Mortality among women participating in the Oxford/Family Planning Association contraceptive study. Lancet 1977; ii: 731
   Google Scholar
• Vessey M. P., Doll R., Jones K., McPherson K., Yeates D. An epidemiological study of oral contraceptives and breast cancer. Br Med J 1979; i: 1755
   Google Scholar
• Weiss N. S., Sayvetz T. A. Incidence of endometrial cancer in relation to the use of oral contraceptives. N Engl J Med 1980; 302: 551
   PubMed Web of Science ®Google Scholar
• Zech P., Riffle G., Lindner A., Sassara J., Blanc Brunat N., Traeger J. Malignant hypertension with irreversible renal failure due to oral contraceptives. Br Med J 1975; iv: 326
   Google Scholar
• Åstedt B. Low fibrinolytic activity of veins during treatment with ethinyloestradiol. Acta Obstet Gynecol Scand 1971; 50: 279
   PubMed Web of Science ®Google Scholar
• Åstedt B., Isacson S., Nilsson I. M., Pandolfi M. Thrombosis and oral contraceptives: possible predisposition. Br Med J 1973; iv: 631
   Google Scholar
• Åstedt B., Jeppsson S. 17β-oestradiol and the fibrinolytic activity of vein walls. J Obstet Gynaecol Br Comvonw 1974; 81: 719
   Google Scholar
• Åstedt B., Jeppsson S., Pandolfi M. Fibrinolytic activity of veins during use of medroxyprogesterone acetate as a contraceptive. Fertil Steril 1972; 23: 489
   Google Scholar
• Åstedt B., Pandolfi M. Ontogenesis of tissue plasminogen activator in the human. Thromb Haemostas 1971; 25: 469
   Google Scholar
• Åstedt B., Svanberg L., Jeppsson S., Liedholm P., Rannevik G. The natural oestrogenic hormone oestradiol as a new component of combined oral contraceptives. Br Med J 1977; i: 269
   Google Scholar
• Åstedt B., Jeppsson S., Liedholm P., Rannevik G., Svanberg L. Clinical trial of a new oral contraceptive pill containing the natural oestrogen 17β-oestradiol. Br J Obstet Gynaecol 1979; 86: 732
   PubMedGoogle Scholar
• Åstedt B., Bernstein K., Casslén B., Ulmsten U. Estrogens and postoperative thrombosis evaluated by the radioactive iodine method. Surg Gynecol Obstet 1980; 151: 372
   Google Scholar
• Boston Collaborative Drug Surveillance Programme. Oral contraceptives and venous thromboembolic disease, surgically confirmed gall bladder disease, and breast tumors. Lancet 1973; i: 1399
   Google Scholar
• Editorial. Oral contraceptives and breast neoplasia. Br Med J 1975; i: 545
   Google Scholar
• Editorial. The pill and raised blood pressure. Br Med J 1976; i: 58
   Google Scholar
• The Royal College of General Practitioners. Oral Contraceptives and Health. An interim report from the oral contraception study of the Royal College of General Practitioners. Pitman Medical, New York 1974
   Google Scholar